GAP Innovations, PBC
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, GAP Innovations, PBC sits in the upper half of US sponsors by registered trial count (#4,885 of 15,742 sponsors by registered trial count).
GAP Innovations, PBC: 2 sponsored US clinical trials, 1 recruiting.
GAP Innovations, PBC sponsors 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 1 completed. The most-studied condition in this pipeline is Memory Impairment, with 1 trials.
Mid-pack sponsor footprint
GAP Innovations, PBC is in the upper half of sponsors by trial count (#4,885 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.
Open and recent trials
2 total, page 1 of 1
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
NCT06584357
A Biomarker Database to Investigate Blood-Based and Digital Biomarkers in Participants Screened for Alzheimer's Disease (Bio-Hermes)
NCT04733989
Therapeutic Areas
What is open in the GAP Innovations, PBC pipeline
1 recruiting of 2 indexed (50% open); 1 completed (50%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Memory Impairment (1 trial), 5 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
GAP Innovations, PBC: open-pipeline peers nationwide
Peers matched on 2 registered trials and 50% open enrollment, not the therapeutic-area sidebar.
GAP Innovations, PBC sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 2 trials (± recruiting share)
- 1200 Pharma · 2 trials · 50% recruiting
- 1ST Biotherapeutics · 2 trials · 50% recruiting
- 3 Waves Wellness · 2 trials · 0% recruiting
- 3EO Health · 2 trials · 0% recruiting
Sponsors near 50% open enrollment (± trial volume)
- 3ive Labs · 50% recruiting · 2 trials
- 60 Degrees Pharmaceuticals · 50% recruiting · 4 trials
- 7 Hills Pharma · 50% recruiting · 2 trials
- Abcentra · 50% recruiting · 2 trials
Related
What to do with this GAP Innovations, PBC page
2 registered trials is a research-attention snapshot, not an endorsement of GAP Innovations, PBC or any single study.
- 1 of GAP Innovations, PBC's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Memory Impairment is the condition GAP Innovations, PBC studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Memory Impairment trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. GAP Innovations, PBC pipeline card: 2 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.